Metraipolis › archive › dc_ebdd7d73dd09

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults — Europe PMC PMID:41729594

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41729594
DOI: 10.1210/clinem/dgag072
License (as archived): solo-consultazione
Archived: 2026-11-01T01:14:25.213Z
SHA-256 of the archived text: 6ea4597675e088037fdf37fb7a2722375256c8a5cb2557673887ff4972a0e76c
Stable URL of this page: https://metraipolis.com/documento/dc_ebdd7d73dd09

How to cite

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults — Europe PMC PMID:41729594 — Europe PMC (en), https://europepmc.org/article/MED/41729594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebdd7d73dd09 (Metraipolis archive dc_ebdd7d73dd09, sha256 6ea4597675e088037fdf37fb7a2722375256c8a5cb2557673887ff4972a0e76c)

BibTeX

@misc{dcebdd7d73dd09,
  title = {The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults — Europe PMC PMID:41729594},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41729594},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebdd7d73dd09; sha256 6ea4597675e088037fdf37fb7a2722375256c8a5cb2557673887ff4972a0e76c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41729594. Agents can read the archived copy with the MCP tool read_document.